Skip to main content
. 2013 Aug;57(8):3536–3546. doi: 10.1128/AAC.00292-13

Table 4.

Structural characterization data for dolutegravir and its metabolites from high-resolution mass spectrometric and NMR analyses

graphic file with name zac00813-1988-t01.jpg

a

RT, retention time.

b

A putative structural isomer is shown.